Follicular Lymphoma

Common Name(s)

Follicular Lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Follicular Lymphoma" returned 808 free, full-text research articles on human participants. First 3 results:

Chemotherapy-Free Treatment of Follicular Lymphoma: We Have the Ingredients, Now for Some Recipes.
 

Author(s): Chan Yoon Cheah, Nathan H Fowler

Journal: Oncology (Williston Park, N.Y.). 2015 Oct;29(10):769, 772.

 

Last Updated: 16 Oct 2015

Go To URL
Cell of origin of transformed follicular lymphoma.
 

Author(s): Robert Kridel, Anja Mottok, Pedro Farinha, Susana Ben-Neriah, Daisuke Ennishi, Yvonne Zheng, Elizabeth A Chavez, Hennady P Shulha, King Tan, Fong Chun Chan, Merrill Boyle, Barbara Meissner, Adele Telenius, Laurie H Sehn, Marco A Marra, Sohrab P Shah, Christian Steidl, Joseph M Connors, David W Scott, Randy D Gascoyne

Journal: Blood. 2015 Oct;126(18):2118-27.

 

Follicular lymphoma (FL) is an indolent disease but transforms in 2% to 3% of patients per year into aggressive, large cell lymphoma, a critical event in the course of the disease associated with increased lymphoma-related mortality. Early transformation cannot be accurately predicted ...

Last Updated: 30 Oct 2015

Go To URL
DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.
 

Author(s): Rada Amin, Frédéric Mourcin, Fabrice Uhel, Céline Pangault, Philippe Ruminy, Loic Dupré, Marion Guirriec, Tony Marchand, Thierry Fest, Thierry Lamy, Karin Tarte

Journal: Blood. 2015 Oct;126(16):1911-20.

 

Follicular lymphoma (FL) results from the accumulation of malignant germinal center (GC) B cells leading to the development of an indolent and largely incurable disease. FL cells remain highly dependent on B-cell receptor (BCR) signaling and on a specific cell microenvironment, including ...

Last Updated: 16 Oct 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Follicular Lymphoma" returned 82 free, full-text review articles on human participants. First 3 results:

Targeted Approaches to the Management of Follicular Lymphoma.
 

Author(s): Chaitra Ujjani

Journal: Oncology (Williston Park, N.Y.). 2015 Oct;29(10):760-8.

 

Despite high rates of response to initial chemoimmunotherapy, patients with follicular lymphoma experience frequent relapses, and better treatment options are needed. Several novel biologic agents have been developed based on a greater understanding of the intrinsic factors driving ...

Last Updated: 16 Oct 2015

Go To URL
Individualized management of follicular lymphoma.
 

Author(s): Bing Bai, Hui-Qiang Huang

Journal: Chin Clin Oncol. 2015 Mar;4(1):7.

 

Follicular lymphoma (FL) is the most common indolent non-hodgkin lymphoma. Most patients with FL are diagnosed with advanced disease and are considered incurable. The classical prognostic index in FL is the FL international prognostic index (FLIPI). The management of FL is mainly ...

Last Updated: 6 Apr 2015

Go To URL
Therapeutic targeting of microenvironment in follicular lymphoma.
 

Author(s): Grzegorz S Nowakowski, Stephen M Ansell

Journal: Hematology Am Soc Hematol Educ Program. 2014 Dec;2014(1):169-73.

 

Immune and nonimmune microenvironmental factors play a critical role in the progression, transformation, and resistance to therapy in follicular lymphoma (FL). A recent increase in our understanding of the role of microenvironment in FL biology has led to the development of novel ...

Last Updated: 20 Feb 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma
 

Status: Recruiting

Condition Summary: Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage II Grade 1 Contiguous Follicular Lymphoma; Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Stage II Grade 2 Contiguous Follicular Lymphoma; Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma

 

Last Updated: 7 Jan 2016

Go to URL
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
 

Status: Recruiting

Condition Summary: Grade 3a Follicular Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma

 

Last Updated: 8 Feb 2016

Go to URL
Idiotypic Vaccination for Follicular Lymphoma Patients
 

Status: Recruiting

Condition Summary: Follicular Lymphoma; First Relapse/Progression

 

Last Updated: 5 Oct 2011

Go to URL